CA
NZ
UK
AU
IND
US
Neonode Inc. filed its quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2026, with the SEC on November 12, 2026, reporting a net loss of $1.137 million for the three-month period.
Darren S. Raiguel, an officer of ePlus Inc., filed a Form 144 notice of proposed sale of 2,783 shares of ePlus common stock, with an approximate sale date of November 11, 2026, through broker Rockefeller Capital Management.
Kapitalo International Fund SPC - Segregated Portfolio J filed a Form 144 notice of proposed sale with the SEC on November 12, 2026, disclosing plans to sell 43 common shares of Aura Minerals Inc. on NASDAQ.
James W. Fugitt, Chief Technology Officer of EZCORP INC (NASDAQ:EZPW), filed a Form 4 on November 12, 2026, reporting the acquisition of 11,761 restricted stock units on November 10, 2026.
Boost Run Inc. filed a Form 8-K with the SEC on November 12, 2026, announcing the release of its financial and operational results for the quarter ended September 30, 2026, along with accompanying earnings conference call materials.
EZCORP Inc. Chief Operations Admin Officer Lucy Hernandez filed a Form 4 on November 12, 2026, disclosing the acquisition of 5,040 Restricted Stock Units on November 10, 2026, tied to Class A Non-Voting Common Stock.
DuPont announced a collaboration with Microsoft and NobleAI on November 12, 2026, aimed at expanding access to AI tools, including machine learning, to help its scientists and engineers accelerate innovation and reduce cycle times for delivering customer solutions.
Adage Capital Management, L.P., together with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, reporting beneficial ownership of 4,190,023 shares of common stock in Camp4 Therapeutics Corporation, a Delaware-incorporated biotherapeutics company headquartered in Watertown, Massachusetts.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of shares in Xilio Therapeutics, Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares of AMR Resources Acquisition Corp. as of September 30, 2026.
Please wait processing your request...